Cargando…
In silico study of HASDI (high-affinity selective DNA intercalator) as a new agent capable of highly selective recognition of the DNA sequence
Cancer as an acquired genetic disease is based on changes both in the genome itself and in transcription processes. Accordingly, it is at the DNA level that it makes sense to search for and design agents capable of effective and selective anticancer action. In this study, we used an iterative approa...
Autores principales: | Zaremba, Andrii A., Zaremba, Polina Yu., Zahorodnia, Svitlana D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070485/ https://www.ncbi.nlm.nih.gov/pubmed/37012345 http://dx.doi.org/10.1038/s41598-023-32595-4 |
Ejemplares similares
-
In vitro and in silico studies of the antiviral activity of polyhydrated fullerenes against influenza A (H1N1) virus
por: Zaremba, Polina, et al.
Publicado: (2023) -
Selective recognition of pyrimidine–pyrimidine DNA mismatches by distance-constrained macrocyclic bis-intercalators
por: Bahr, Matthias, et al.
Publicado: (2008) -
Radiosensitization by the novel DNA intercalating agent vosaroxin
por: Gordon, Ira K, et al.
Publicado: (2012) -
Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity
por: Kang, Dezhi, et al.
Publicado: (2012) -
Synthesis of Acridine-based DNA Bis-intercalating Agents
por: Moloney, Gerard P., et al.
Publicado: (2001)